Topical steroids and emollients in atopic eczema - which should be applied first?
Topical steroids and emollients in atopic eczema - which should be applied first?
Atopic eczema is one of the most common skin diseases but it is still often poorly managed by patients and health professionals. David Voegli examines the latest knowledge of the topic and how it can improve treatment
Atopic eczema (AE) is one of the most common dermatological diseases, with the number of cases in the UK rising. The use of emollients to maintain skin hydration and restore barrier function remains the principal treatment, in conjunction with topical corticosteroids (TCS) to reduce inflammation. Unfortunately, many health professionals, and patients themselves, fail to consider emollients as an active treatment and may overlook the vital role they play in the maintenance of intact, healthy skin. Despite the overwhelming acceptance of the importance of emollient therapy, there remains a lack of good quality evidence on their effectiveness or whether one is better than another. Patients often receive conflicting or limited advice from health professionals as to how to use them, and if using TCS as well, which to apply first. This may result in incorrect use, reduced therapeutic effect and poor concordance. This article aims to explore normal skin barrier function, the disruption caused by AE, and some of the contemporary issues surrounding emollient therapy and topical corticosteroids.
atopic eczema, atopic dermatitis, skin barrier function, emollients, topical corticosteroids
14-20
Voegeli, David
e6f5d112-55b0-40c1-a6ad-8929a2d84a10
January 2017
Voegeli, David
e6f5d112-55b0-40c1-a6ad-8929a2d84a10
Voegeli, David
(2017)
Topical steroids and emollients in atopic eczema - which should be applied first?
Practice Nursing, 28 (1), .
(doi:10.12968/pnur.2017.28.1.14).
Abstract
Atopic eczema is one of the most common skin diseases but it is still often poorly managed by patients and health professionals. David Voegli examines the latest knowledge of the topic and how it can improve treatment
Atopic eczema (AE) is one of the most common dermatological diseases, with the number of cases in the UK rising. The use of emollients to maintain skin hydration and restore barrier function remains the principal treatment, in conjunction with topical corticosteroids (TCS) to reduce inflammation. Unfortunately, many health professionals, and patients themselves, fail to consider emollients as an active treatment and may overlook the vital role they play in the maintenance of intact, healthy skin. Despite the overwhelming acceptance of the importance of emollient therapy, there remains a lack of good quality evidence on their effectiveness or whether one is better than another. Patients often receive conflicting or limited advice from health professionals as to how to use them, and if using TCS as well, which to apply first. This may result in incorrect use, reduced therapeutic effect and poor concordance. This article aims to explore normal skin barrier function, the disruption caused by AE, and some of the contemporary issues surrounding emollient therapy and topical corticosteroids.
Text
Practice Nursing TCS & emollients 2016 Revised
- Accepted Manuscript
More information
Accepted/In Press date: 20 December 2016
e-pub ahead of print date: 24 January 2017
Published date: January 2017
Keywords:
atopic eczema, atopic dermatitis, skin barrier function, emollients, topical corticosteroids
Organisations:
Advancing Clinical & Expert Practice
Identifiers
Local EPrints ID: 407651
URI: http://eprints.soton.ac.uk/id/eprint/407651
ISSN: 0964-9271
PURE UUID: a4110058-30c9-4439-ac87-26a4f21f15bf
Catalogue record
Date deposited: 16 Apr 2017 17:09
Last modified: 15 Mar 2024 12:25
Export record
Altmetrics
Contributors
Author:
David Voegeli
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics